Skip to main navigation Skip to search Skip to main content

The Capital Region of Denmark's Research Portal Home

- Dansk
- English

Search content at The Capital Region of Denmark's Research Portal

Home
Hospitals/Departments
Researchers
Research output
Activities
Prizes

Astma-COPD Overlap Syndrome (ACOS): A disease entity or co-existing asthma and COPD?

Camilla Boslev Bårnes

Respiratory Unit
www.ccrp.dk

Overview

Original language	English
Publication status	Published - 2018

Cite this

APA
Standard
Harvard
Vancouver
Author
BIBTEX
RIS

Boslev Bårnes, C. (2018). Astma-COPD Overlap Syndrome (ACOS): A disease entity or co-existing asthma and COPD?

Astma-COPD Overlap Syndrome (ACOS): A disease entity or co-existing asthma and COPD? / Boslev Bårnes, Camilla .
2018.

Research output: Theses › Ph.d. Thesis

Boslev Bårnes, C 2018, 'Astma-COPD Overlap Syndrome (ACOS): A disease entity or co-existing asthma and COPD?'.

Boslev Bårnes C. Astma-COPD Overlap Syndrome (ACOS): A disease entity or co-existing asthma and COPD?. 2018.

Boslev Bårnes, Camilla . / Astma-COPD Overlap Syndrome (ACOS): A disease entity or co-existing asthma and COPD?. 2018.

@misc{b0fca367331d46ca9ce99eff7d9d75f0,

title = "Astma-COPD Overlap Syndrome (ACOS): A disease entity or co-existing asthma and COPD?",

author = "\{Boslev B{\aa}rnes\}, Camilla",

year = "2018",

language = "English",

}

TY - GEN

T1 - Astma-COPD Overlap Syndrome (ACOS): A disease entity or co-existing asthma and COPD?

AU - Boslev Bårnes, Camilla

PY - 2018

Y1 - 2018

M3 - Ph.d. Thesis

ER -

Powered by Pure Link opens in a new tab, Scopus Link opens in a new tab & Elsevier Fingerprint Engine™ Link opens in a new tab

All content on this site: Copyright © 2026 The Capital Region of Denmark's Research Portal, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply

We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of cookies

About web accessibility Link opens in a new tab

Report vulnerability Link opens in a new tab